Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study assessing pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions

Trial Profile

A study assessing pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Sep 2018

At a glance

  • Drugs Oxycodone/naloxone (Primary)
  • Indications Constipation; Interstitial cystitis; Pain; Restless legs syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Sep 2018 New trial record
    • 05 Sep 2018 Results published in the Nephrology Dialysis Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top